180 Life Sciences Balance Sheet Health
Financial Health criteria checks 2/6
180 Life Sciences has a total shareholder equity of $3.7M and total debt of $483.7K, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are $10.5M and $6.7M respectively.
Key information
13.0%
Debt to equity ratio
US$483.72k
Debt
| Interest coverage ratio | n/a |
| Cash | US$194.92k |
| Equity | US$3.73m |
| Total liabilities | US$6.74m |
| Total assets | US$10.47m |
Recent financial health updates
Recent updates
180 Life Sciences to raise $6.5M in direct stock offering
Jul 18180 Life Sciences: Looking At Inflammation With Cannabis (Podcast)
Sep 08What Type Of Shareholders Make Up 180 Life Sciences Corp.'s (NASDAQ:ATNF) Share Registry?
Feb 17
SPAC biotech 180 Life Sciences to ring Nasdaq opening bell today
Nov 27Financial Position Analysis
Short Term Liabilities: ATNF's short term assets ($1.2M) do not cover its short term liabilities ($6.4M).
Long Term Liabilities: ATNF's short term assets ($1.2M) exceed its long term liabilities ($352.3K).
Debt to Equity History and Analysis
Debt Level: ATNF's net debt to equity ratio (7.7%) is considered satisfactory.
Reducing Debt: ATNF's debt to equity ratio has increased from 6.1% to 13% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATNF has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ATNF has less than a year of cash runway if free cash flow continues to reduce at historical rates of 13.5% each year